摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基壬酸 | 5440-35-7

中文名称
2-氨基壬酸
中文别名
2-氨基正壬酸
英文名称
2-Amino-pelargonsaeure
英文别名
2-aminononanoic acid;2-azaniumylnonanoate
2-氨基壬酸化学式
CAS
5440-35-7
化学式
C9H19NO2
mdl
——
分子量
173.255
InChiKey
JVPFOKXICYJJSC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    ~280 °C (dec.)
  • 沸点:
    284.5±23.0℃ (760 Torr)
  • 密度:
    0.985±0.06 g/cm3 (20 ºC 760 Torr)
  • 闪点:
    125.9±22.6℃

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    12
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36
  • 危险类别码:
    R36
  • WGK Germany:
    3
  • 海关编码:
    2922499990

SDS

SDS:4c498c063b87a2688f962daa98ff3855
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氨基壬酸palladium dihydroxide lithium aluminium tetrahydride 、 草酰氯氢气potassium carbonate二甲基亚砜三乙胺 作用下, 以 四氢呋喃甲醇正己烷二氯甲烷甲苯 为溶剂, -60.0~80.0 ℃ 、101.33 kPa 条件下, 生成 (+/-)-N-tert-butoxycarbonyl-O-methanesulfonyl-3-aminodecan-2-ol
    参考文献:
    名称:
    4,5-Dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors
    摘要:
    In the course of our search for selective iNOS inhibitors, we have previously reported that 2-imino-1,3-oxazolidine derivatives (1) and 2-aminothiazole derivatives (2) are selective iNOS inhibitors. In order to find more potent iNOS inhibitors, we focused our efforts on the synthesis and evaluation of the inhibitory activity against iNOS and selectivity for iNOS both in vitro and in vivo of a series of 2-imino-1,3-thiazolidine derivatives (3), which are analogues of I and 2. Our results show that among the compounds synthesized (4R,5R)-5-ethyl-2-imino-4-methyl-1,3-thiazolidine [(4R,5R)-14a: ES-1537] exhibited potent inhibitory activity and selectivity for iNOS. In addition, ES-1537 had good pharmacokinetic profile in rats with BA value of 80%. It is therefore expected that ES-1537 may be therapeutically useful for the treatment of diseases related to excess production of NO. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.05.031
  • 作为产物:
    参考文献:
    名称:
    Albertson, Journal of the American Chemical Society, 1946, vol. 68, p. 452
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • The Preparation of Some Substituted Thiohydantoins and Thioimidazoles
    作者:Mary Jackman、Mabel Klenk、B. Fishburn、B. F. Tullar、S. Archer
    DOI:10.1021/ja01189a015
    日期:1948.9
    It has been shown that proper substitution a t the six position in 2-thiouracil resulted in increased antithyroid activity.' Astwood showed that 2thiohydantoin was half and 2-thioimidazole one and one half times as active as 2-thiouracil in goitrogenic potency.2 It seemed likely then that appropriately substituted thiohydantoins and thioimidazoles would show greater activity than the parent heterocycles
    已经表明,在 2-硫尿嘧啶的第 6 个位置上的适当取代导致抗甲状腺活性增加。Astwood 表明,在致甲状腺肿的效力方面,2-硫代乙内酰脲的活性是 2-硫代乙内酰脲的一半,而 2-硫代咪唑的活性是 2-硫尿嘧啶的二分之一。2 看来,适当取代的硫代乙内酰脲和硫代咪唑可能比母体杂环表现出更大的活性。因此,已经制备了许多用于药理学筛选的 5-烷基-2-硫代乙内酰脲和 4-烷基-2-硫代咪唑。Wheeler 和同事通过氨基酸和硫氰酸铵在乙酸酐中的相互作用制备了烷基硫代乙内酰脲,首先得到 l-乙酰基-5-烷基-2 硫代乙内酰脲,它在与盐酸一起煮沸时失去乙酰基. 大多数需要的氨基酸是通过Albert-on的方法制备的。在所有情况下,中间乙酰基体未经纯化就进行水解裂解。在遇到油性乙酰硫代乙内酰脲的少数情况下,淬灭的反应混合物用氯仿萃取,并如实验部分所述进行进一步处理。4-烷基-2-硫代咪唑是由相应的氨基
  • Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
    申请人:——
    公开号:US20030176486A1
    公开(公告)日:2003-09-18
    The present invention relates to a novel sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof. More particularly, the present invention relates to a sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof, which is useful as an inhibitor of lipopolysaccharides (LPS). In addition, the present invention relates to a novel intermediate compound useful for the synthesis of this sulfonic acid derivative of hydroxamic acid.
    本发明涉及羟羰酸的新型磺酸衍生物或其药理学上可接受的盐。更具体地,本发明涉及一种羟羰酸的磺酸衍生物或其药理学上可接受的盐,其用作脂多糖(LPS)的抑制剂。此外,本发明涉及一种新型中间化合物,用于合成这种羟羰酸的磺酸衍生物。
  • Inhibitors of hepatitis C virus NS3 protease
    申请人:——
    公开号:US20020065248A1
    公开(公告)日:2002-05-30
    The present invention relates to compounds of Formula (I): 1 wherein A 1 is methylene, ethylene or propylene group and A 2 is N or CR 5 , or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    本发明涉及化合物的结构公式(I):其中A1为亚甲基、乙烯基或丙烯基,A2为N或CR5,或其立体异构体形式、立体异构体混合物或药用盐形式,用作HCV NS3蛋白酶的抑制剂,以及包含相同化合物的药物组合物和诊断试剂盒,以及用于治疗病毒感染或作为测定标准或试剂的方法。
  • NOVEL CYCLIC DEPSIPEPTIDE DERIVATIVES AND HARMFUL ORGANISM CONTROL AGENTS COMPRISING THE SAME
    申请人:Meiji Seika Pharma Co., Ltd.
    公开号:US20170215422A1
    公开(公告)日:2017-08-03
    An objective of the present invention is to provide novel cyclic depsipeptide derivatives and harmful organism control agents including the same as each other. Specifically, the present invention provides compounds represented by formula (1) or stereoisomers thereof, harmful organism control agents containing them, and a process for producing them.
    本发明的目标是提供新型的环状脱氨肽衍生物和包括它们的有害生物控制剂。具体而言,本发明提供由公式(1)或其立体异构体表示的化合物,包含它们的有害生物控制剂,以及生产它们的方法。
  • METHOD FOR PRODUCING MEDIUM-CHAIN OMEGA-HYDROXY FATTY ACIDS, ALPHA,OMEGA-DICARBOXYLIC ACIDS, AND OMEGA-AMINO FATTY ACIDS FROM LONG-CHAIN FATTY ACIDS BY BIOTRANSFORMATION
    申请人:EHWA UNIVERSITY - UNIVERSITY COLLABORATION FOUNDATION
    公开号:US20150057461A1
    公开(公告)日:2015-02-26
    The present invention relates to a transformant which is transformed to express Baeyer-Villiger monooxygenase (BVMO), a method for producing C5-C14 medium-chain ω-hydroxy fatty acids, α,ω-dicarboxylic acids, ω-amino fatty acids, or alcohols from C16-C20 long-chain fatty acids by biotransformation using the transformant, a method for producing a fatty acid derivative having an ester group which is introduced into the chain thereof from keto fatty acid using the BVMO, and novel ω-hydroxy fatty acids which are prepared by the method. Degradation products such as C5 to C14 ω-hydroxy fatty acids, α,ω-dicarboxylic acids, ω-amino fatty acids, alcohols can be produced in a large amount from C16 to C20 long-chain fatty acids contained in a medium by biotransformation using a transformant capable of expressing BVMO of the present invention. Therefore, it can be widely used to produce ω-hydroxy fatty acids, α,ω-dicarboxylic acids, ω-amino fatty acids or alcohols in a more safe and economic manner.
    本发明涉及一种转化体,该转化体被转化以表达Baeyer-Villiger单加氧酶(BVMO),以及通过使用该转化体进行生物转化从C16-C20长链脂肪酸中生产C5-C14中链ω-羟基脂肪酸、α,ω-二羧酸、ω-氨基脂肪酸或醇的方法,以及使用BVMO从酮脂肪酸中引入酯基的脂肪酸衍生物的制备方法和新的ω-羟基脂肪酸。通过使用本发明的能够表达BVMO的转化体进行生物转化,可以从介质中含有的C16到C20长链脂肪酸中大量生产C5到C14的ω-羟基脂肪酸、α,ω-二羧酸、ω-氨基脂肪酸、醇等降解产物。因此,它可以广泛用于更安全、更经济地生产ω-羟基脂肪酸、α,ω-二羧酸、ω-氨基脂肪酸或醇。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物